Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

SABCS 2011

11 Nov 2011
Renaissance Zurich Hotel, Zurich, Switzerland
Energy supply in cancer
Dr Michael Pollak - McGill Univeristy, Montreal, Canada
Energy supply in cancer ( Dr Michael Pollak - McGill Univeristy, Montreal, Canada )
20 Dec 2011
A new test to determine risk of recurrence in DCIS breast cancer
Dr Larry Solin - Albert Einstein Medical Center, Philadelphia, USA
A new test to determine risk of recurrence in DCIS breast cancer ( Dr Larry Solin - Albert Einstein Medical Center, Philadelphia, USA )
20 Dec 2011
A test to predict risk of recurrence in DCIS
Prof Joseph Sparano - Albert Einstein Cancer Center, New York, USA
A test to predict risk of recurrence in DCIS ( Prof Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
20 Dec 2011
Axillary dissection may be overtreatment in some breast cancer patients
Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy
Axillary dissection may be overtreatment in some breast cancer patients ( Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy )
20 Dec 2011
Clinical research within developing countries
Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India
Clinical research within developing countries  ( Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India )
20 Dec 2011
Results from the GeparQuinto trial
Dr Jens Huober - Kantonsspital St.Gallen, Breast Center, Switzerland
Results from the GeparQuinto trial ( Dr Jens Huober - Kantonsspital St.Gallen, Breast Center, Switzerland )
20 Dec 2011
Analysis of the development of breast tissue
Prof Geoff Wahl – University of California, San Diego, USA
Analysis of the development of breast tissue ( Prof Geoff Wahl – University of California, San Diego, USA )
20 Dec 2011
Link between vitamin D levels and breast cancer
Dr Eitan Amir – Princess Margaret Hospital, Toronto, Canada
Link between vitamin D levels and breast cancer ( Dr Eitan Amir – Princess Margaret Hospital, Toronto, Canada )
20 Dec 2011
Biological differences in breast cancer cases due to age
Dr Ann Partridge – Dana-Farber Cancer Institute, Boston, USA
Biological differences in breast cancer cases due to age ( Dr Ann Partridge – Dana-Farber Cancer Institute, Boston, USA )
20 Dec 2011
The latest for advanced breast cancer
Dr Hope Rugo – University of San Francisco, California USA
The latest for advanced breast cancer ( Dr Hope Rugo – University of San Francisco, California USA )
20 Dec 2011
Long term effects oophorectomy, at a young age, on bone health
Dr Anne Marie McCarthy - Johns Hopkins Bloomberg School of Public Health, Baltim...
Long term effects oophorectomy, at a young age, on bone health ( Dr Anne Marie McCarthy - Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA )
16 Dec 2011
Everolimus for postmenopausal women with advanced breast cancer
Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA
Everolimus for postmenopausal women with advanced breast cancer ( Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA )
16 Dec 2011
Randomized Phase II Study in Patients with HER2-Positive Breast Cancer
Dr Luca Gianni - Ospedale San Raffaele, Milan, Italy
Randomized Phase II Study in Patients with HER2-Positive Breast Cancer  ( Dr Luca Gianni - Ospedale San Raffaele, Milan, Italy )
16 Dec 2011
Effects of breast reconstructive surgery after mastectomy
Dr Dawn Hershman - Columbia University Medical Center, New York, NY
Effects of breast reconstructive surgery after mastectomy ( Dr Dawn Hershman - Columbia University Medical Center, New York, NY )
16 Dec 2011
Influence of age and BRCA status on contralateral breast cancer risk
Alexandra van den Broek - Netherlands Cancer Institute, Amsterdam
Influence of age and BRCA status on contralateral breast cancer risk ( Alexandra van den Broek - Netherlands Cancer Institute, Amsterdam )
16 Dec 2011
Treatment of breast cancer as a chronic disease
Dr Vered Stearns - John Hopkins Medicine, Baltimore, USA
Treatment of breast cancer as a chronic disease ( Dr Vered Stearns - John Hopkins Medicine, Baltimore, USA )
16 Dec 2011
Genetic differences responsible for outcome in hormone receptor positive early s...
Prof Minetta Liu - Georgetown University, Washington, USA
Genetic differences responsible for outcome in hormone receptor positive early stage breast cancer ( Prof Minetta Liu - Georgetown University, Washington, USA )
16 Dec 2011
Everolimus improved PFS in advanced hormone receptor positive breast cancer
Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA
Everolimus improved PFS in advanced hormone receptor positive breast cancer ( Dr Gabriel Hortobagyi - MD Anderson Cancer Center, Houston, Texas, USA )
16 Dec 2011
Breast cancer, exercise and weight loss
Dr Jennifer Ligibel - Dana-Faber Cancer Institute, Boston, USA
Breast cancer, exercise and weight loss ( Dr Jennifer Ligibel - Dana-Faber Cancer Institute, Boston, USA )
16 Dec 2011
Bevacizumab improves PFS in HER-2-positive breast cancer
Prof Luca Gianni - Università Vita-Salute San Raffaele, Milan, Italy
Bevacizumab improves PFS in HER-2-positive breast cancer ( Prof Luca Gianni - Università Vita-Salute San Raffaele, Milan, Italy )
16 Dec 2011
Links between early life exposures and breast cancer
Prof Michele Forman - University of Texas, Austin, USA
Links between early life exposures and breast cancer ( Prof Michele Forman - University of Texas, Austin, USA )
16 Dec 2011
Use of neutrophils to prevent lung metastases in breast cancer patients
Dr Robert Benezra - Memorial Sloan-Kettering Cancer Center, New York, USA
Use of neutrophils to prevent lung metastases in breast cancer patients ( Dr Robert Benezra - Memorial Sloan-Kettering Cancer Center, New York, USA )
16 Dec 2011
CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab ...
Prof Jose Baselga - Massachusetts General Hospital Cancer Center, Boston, MA
CLEOPATRA trial to evaluate the efficacy and safety of pertuzumab + trastuzumab + docetaxel  ( Prof Jose Baselga - Massachusetts General Hospital Cancer Center, Boston, MA )
14 Dec 2011